Sandoz Egypt Pharma and Ibnsina Pharma ink strategic partnership to improve patient access to OTC Products
Sandoz Egypt Pharma and Ibnsina Pharma have announced a distribution and promotion agreement for the Sandoz over-the-counter (OTC) portfolio of products, strengthening the company’s commitment to widening access to products, with the help of Ibnsina’s expansive nationwide network. The broad outlines of the agreement amplify both companies’ efforts to reach a higher number of underserved patients.
Sameh Elbagoury, General Manager at Sandoz Egypt and Libya, said: “OTC products are vital to advancing healthcare, and our partnership with a true market leader like Ibn Sina is an important step, catalyzing our ability on-ground to live up to our relentless commitment to improving access. Our OTC portfolio in Egypt currently spans eight products and we have concrete plans to expand, transforming it into one of our strategic pillars, alongside our generic and biosimilar drug portfolios.”